BSE Code :
NSE Symbol :
ISIN :
Industry :

Trade Now

Get Quotes

643.50 0.00(0.00%)

Open Price (₹)

650.00

Prev. Close (₹)

643.50

Volume (No’s)

390,845

Market Cap (₹)

0

Low Price (₹)

635.10

High Price (₹)

655.00 Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Board Meetings

Start Date	End Date	Purpose
04-May-2016	13-May-2016	Advanta Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2016, inter alia, to consider the following: 1. Audited Financial Statements (standalone and consolidated) for the financial year (Fifteen months period) ended March 31, 2016. 2. Statement of audited financial results (standalone and consolidated) for the quarter and year (fifteen months period) ended March 31, 2016 as required under Regulation 33 of SEBI Listing Regulations. In this connection, as per the Company's Code on Insider Trading, the trading window for dealing in the securities of the Company will remain closed for designated persons and their immediate relatives from May 05, 2016 to May 15, 2016 (both days inclusive). With reference to the earlier letter dated May 04, 2016 regarding Notice of Board Meeting to be held on May 13, 2016, Advanta Ltd has now informed BSE that the following items of business will also be transacted in the board meeting to be held on May 13, 2016: 1. To consider and approve the conversion notice received from the FCCB holders; 2. To consider and approve the allotment of equity shares and 3. To consider and approve the issue of GDRs upon conversion of FCCBs. (As per BSE Announcement dated on 10.05.2016)
01-Mar-2016	01-Mar-2016	Advanta Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 01, 2016, has considered and approved the following with immediate effect: 1. Resignation of Mr. Claudio Torres as Global CEO. 2. Appointment of Mr. Bhupen Dubey as Global CEO.
22-Jan-2016	29-Jan-2016	Advanta Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on January 29, 2016, inter alia, to consider and approve the un-audited financial results of the Company for the quarter ended December 31, 2015. In this connection, as per the Company's Code on Insider Trading, the trading window for dealing in the securities of the Company will remain closed for Designated persons and their immediate relatives from January 23, 2016 to January 31, 2016 (both days inclusive). Advanta Ltd has informed BSE that pursuant to the provisions of Section 2(41) of Companies Act, 2013, the Company has aligned its financial year from January to March. In view of this, the current financial year of the Company will be for a period of 15 months i.e. from January 01, 2015 to March 31, 2016. (As Per BSE Announcement Dated on 30.01.2016)
28-Dec-2015	31-Dec-2015	Advanta Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on December 31, 2015, inter alia, to consider and approve the following: 1. conversion notice received from the FCCB holders; 2. allotment of equity shares and issue of GDRs upon conversion of FCCBs In this connection, as per the Company's Code on Insider Trading, the trading window for dealing in the securities of the Company will remain closed for Designated persons and their immediate relatives from December 29, 2015 to January 02, 2016 (both days inclusive). Advanta Ltd has informed BSE that the Board of Directors of the Company at its meeting held on December 31, 2015, inter alia, have transacted the following items of business: 1. Approved the conversion of 25 Foreign Currency Convertible Bonds (FCCBs) into Global Depository Receipts (GDRs). 2. Approved the allotment of 39,72,070 equity shares of Rs. 2 each to JP Morgan Chase Bank, NA - Depository Bank, to issue appropriate GDRs. (As Per BSE Announcement Dated on 31.12.2015)
20-Nov-2015	23-Nov-2015	Advanta Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on November 23, 2015, to consider and approve the Scheme of Amalgamation of the Company with UPL Limited. In this connection, as per the Company's Code on Insider Trading, the trading window for dealing in the securities of the Company will remain closed for Designated persons and their immediate relatives from November 21, 2015 to November 25, 2015 (both days inclusive). Advanta Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 23, 2015, has considered and approved inter alia the proposal for the amalgamation of Advanta Limited ('Transferor Company') with UPL Limited ('Transferee Company'). The proposal will be implemented by a Scheme of Amalgamation ('Scheme') under the provisions of Sections 391-394 of the Companies Act, 1956 and other applicable provisions as may be amended from time-to-time. The appointed date of the Scheme has been fixed as April 01, 2015. In consideration for the transfer of and vesting of all the assets and liabilities of the Transferor Company as above, the Transferee Company would issue the securities in the following manner: A. Exchange Ratio for Equity Shareholders of the Transferor Company To the equity shareholders of the Transferor Company (whose names are registered in the Register of Members of the Transferor Company /register of beneficial owner with depository on the Record Date, or his /her/its legal heirs, executors or administrators or, as the case may be, successors) the following shares (the 'Share Exchange Ratio'): For every one equity share of the Transferor Company of the face value of Rs. 2/- (Rupees Two) each fully paid up held by the shareholders of the Transferor Company on the Record Date following shares will be issued: (a) One equity share of the Transferee Company of Rs. 2/- (Rupees Two) each fully paid up (the 'New Equity Shares'): and (b) Three preference shares of the Transferee Company of Rs. 10/- (Rupees Ten) each folly paid up, (the 'Preference Shares') issued in the following manner: (i) On the Record Date, if the shareholder is a Person Resident Outside India, three compulsorily convertible preference shares of the Transferee Company of Rs. 10/- (Rupees Ten) each folly paid up, (the 'CCPS') will be issued which will be convertible into equity shares of the Transferee Company, subject to terms specified in Schedule 1 to the Scheme. (ii) On the Record Date, if the shareholder is a Person Resident in India, three optionally convertible preference shares of the Transferee Company of Rs. 10/- (Rupees Ten) each fully paid up, (the 'OCPS') will be issued which will be convertible into equity shares of the Transferee Company or redeemable, subject to terms specified in Schedule 2 to the Scheme. B. Exchange Ratio for GDR Holders of the Transferor Company For every 100 (One Hundred) GDRs held in the Transferor Company on the Record Date, the Transferor Company GDR holders would be entitled to 106 (One Hundred Six) Transferee Company New GDRs. C. Exchange Ratio for FCCB Holders of the Transferor Company For every 100 (One Hundred) FCCBs held in the Transferor Company on the Record Date, the FCCB holders of the Transferor Company, would be entitled to 100 (One Hundred) Transferee Company FCCBs and the conversion formula for the Transferee Company FCCBs shall be as specified in clause 8.16(i) of the Scheme. The Share Exchange Ratio is recommended by M/s. BSR & Associates LLP on which Kotak Mahindra Capital Company Limited has issued fairness opinion. The Transferee Company holds around 48.44% shareholding of the Transferor Company and the same shall stand cancelled on amalgamation. The above proposal is subject to the satisfaction of various conditions, including obtaining necessary approvals from the shareholders, creditors and regulatory authorities including the Securities and Exchange Board of India ('SEBI'), Stock Exchanges under the Listing Agreement, Competition Commission of India, Reserve Bank of India, and sanction of the Scheme by the relevant High Court(s) and/or any other appropriate authority as may be necessary. Rationale of the Scheme: To amalgamate the seed business of the Transferor Company with the Crop Protection Chemical and Post-Harvest Business of the Transferee Company and thereby provide end to end agri solution through a single entity. The amalgamation of Transferor Company with the Transferee Company would inter alia have the following benefits: (a) Geographical Expansion. The combination of the Transferor Company and Transferee Company would provide access to newer territories, better coverage in the existing territories and will help to further leverage existing distribution channels. The expanded reach of the Transferee Company would be particularly beneficial for capitalizing on growth opportunities. (b) Customer access The Transferee Company would be in a position to provide complete crop solutions to farmers. The seed portfolio facilitates early and direct farmer engagements which would promote sale of Crop Protection Chemicals and Post-Harvest products and build customer loyalty. (c) Presence across agri-inputs value chain. The Transferee Company, with seeds, Crop Protection Chemicals and Post-Harvest product portfolio, shall reap benefit of larger range of agri input products. (d) Greater Focus. Transferee Company will be able to achieve economies of scale, greater efficiency, optimization of logistic and distribution network and other related economies. The final Scheme as approved at the Board meeting held on November 23, 2015 shall be filed with the Stock Exchange in compliance with the provisions of Clause 24(f) of the listing agreement and would be available on the website of the Company post filing of the same with the stock exchanges. (As Per BSE Announcement Dated on 23.11.2015)